» Articles » PMID: 37483952

Intervertebral Disc Degeneration-Current Therapeutic Options and Challenges

Overview
Specialty Public Health
Date 2023 Jul 24
PMID 37483952
Authors
Affiliations
Soon will be listed here.
Abstract

Degeneration of the intervertebral disc (IVD) is a normal part of aging. Due to the spine's declining function and the development of pain, it may affect one's physical health, mental health, and socioeconomic status. Most of the intervertebral disc degeneration (IVDD) therapies today focus on the symptoms of low back pain rather than the underlying etiology or mechanical function of the disc. The deteriorated disc is typically not restored by conservative or surgical therapies that largely focus on correcting symptoms and structural abnormalities. To enhance the clinical outcome and the quality of life of a patient, several therapeutic modalities have been created. In this review, we discuss genetic and environmental causes of IVDD and describe promising modern endogenous and exogenous therapeutic approaches including their applicability and relevance to the degeneration process.

Citing Articles

Gallic acid protects intervertebral disc cells from ferroptosis and alleviates intervertebral disc degeneration by regulating key factors of oxidative stress.

Zhu Z, Huang Z, Zhang C, Xu B, Chen H, Pei S Front Pharmacol. 2025; 16:1501725.

PMID: 39963245 PMC: 11830718. DOI: 10.3389/fphar.2025.1501725.


Pyroptosis: candidate key targets for mesenchymal stem cell-derived exosomes for the treatment of bone-related diseases.

Li H, Zhang P, Lin M, Li K, Zhang C, He X Stem Cell Res Ther. 2025; 16(1):68.

PMID: 39940049 PMC: 11816542. DOI: 10.1186/s13287-025-04167-y.


Innovating intervertebral disc degeneration therapy: Harnessing the power of extracellular vesicles.

Chen S, Dou Y, Zhang Y, Sun X, Liu X, Yang Q J Orthop Translat. 2025; 50:44-55.

PMID: 39868351 PMC: 11761297. DOI: 10.1016/j.jot.2024.09.014.


Targeting nucleus pulposus cell death in the treatment of intervertebral disc degeneration.

Sun H, Guo J, Xiong Z, Zhuang Y, Ning X, Liu M JOR Spine. 2024; 7(4):e70011.

PMID: 39703198 PMC: 11655182. DOI: 10.1002/jsp2.70011.


Alginate vs. Hyaluronic Acid as Carriers for Nucleus Pulposus Cells: A Study on Regenerative Outcomes in Disc Degeneration.

Ogasawara S, Schol J, Sakai D, Warita T, Susumu T, Nakamura Y Cells. 2024; 13(23).

PMID: 39682732 PMC: 11639827. DOI: 10.3390/cells13231984.


References
1.
Varden L, Nguyen D, Michalek A . Slow depressurization following intradiscal injection leads to injectate leakage in a large animal model. JOR Spine. 2019; 2(3):e1061. PMC: 6764785. DOI: 10.1002/jsp2.1061. View

2.
Risbud M, Guttapalli A, Tsai T, Lee J, Danielson K, Vaccaro A . Evidence for skeletal progenitor cells in the degenerate human intervertebral disc. Spine (Phila Pa 1976). 2007; 32(23):2537-44. DOI: 10.1097/BRS.0b013e318158dea6. View

3.
Berman D, Oren J, Bendo J, Spivak J . The Effect of Smoking on Spinal Fusion. Int J Spine Surg. 2018; 11:29. PMC: 5779238. DOI: 10.14444/4029. View

4.
Nasto L, Ngo K, Leme A, Robinson A, Dong Q, Roughley P . Investigating the role of DNA damage in tobacco smoking-induced spine degeneration. Spine J. 2013; 14(3):416-23. PMC: 3944725. DOI: 10.1016/j.spinee.2013.08.034. View

5.
Chen F, Jiang G, Liu H, Li Z, Pei Y, Wang H . Melatonin alleviates intervertebral disc degeneration by disrupting the IL-1β/NF-κB-NLRP3 inflammasome positive feedback loop. Bone Res. 2020; 8:10. PMC: 7028926. DOI: 10.1038/s41413-020-0087-2. View